Northwest Biotherapeutics reported -120525000 in Equity Capital and Reserves for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Agenus AGEN:US $ 15.72M 18.72M
Applied Genetic Technologies AGTC:US $ 47.03M 4.46M
AstraZeneca AZN:LN 36340M 2928M
Bristol Myers Squibb BMY:US $ 31580M 4366M
Celldex Therapeutics CLDX:US $ 398.1M 21.38M
Cti Biopharma CTIC:US $ -27.92M 31.68M
Cytori Therapeutics CYTX:US $ 14.64M 3.81M
Cytrx CYTR:US 3.28M 1.5M
Eisai 4523:JP Y 748822M 14034M
Genocea Biosciences GNCA:US $ 12.38M 14.69M
Infinity Pharmaceuticals INFI:US $ 9.98M 11.59M
Merk MRK:US $ 40883M 2699M
Mirati Therapeutics MRTX:US $ 1249.28M 147.76M
Northwest Biotherapeutics NWBO:US -120525000 3.47M
Pfizer PFE:US $ 82424M 5224M